scholarly article | Q13442814 |
P356 | DOI | 10.1007/S40519-018-0599-6 |
P698 | PubMed publication ID | 30353455 |
P50 | author | Gianluca Gortan Cappellari | Q57909428 |
P2093 | author name string | Rocco Barazzoni | |
P2860 | cites work | Randomized Phase II Study of the Anti-inflammatory Effect of Ghrelin During the Postoperative Period of Esophagectomy | Q85894772 |
Acylated and unacylated ghrelin during OGTT in Prader-Willi syndrome: support for normal response to food intake | Q87238196 | ||
Central adiposity markers, plasma lipid profile and cardiometabolic risk prediction in overweight-obese individuals | Q88741178 | ||
Sarcopenic obesity: Time to meet the challenge | Q88953727 | ||
Ghrelin is a growth-hormone-releasing acylated peptide from stomach | Q22010951 | ||
GH, GH receptor, GH secretagogue receptor, and ghrelin expression in human T cells, B cells, and neutrophils | Q24291670 | ||
Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells | Q24298483 | ||
A receptor in pituitary and hypothalamus that functions in growth hormone release | Q24308321 | ||
Ghrelin octanoylation mediated by an orphan lipid transferase | Q24336259 | ||
Mice lacking ghrelin receptors resist the development of diet-induced obesity | Q24536127 | ||
Revised genomic structure of the human ghrelin gene and identification of novel exons, alternative splice variants and natural antisense transcripts | Q24564988 | ||
Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction | Q24632414 | ||
Exogenous ghrelin modulates release of pro-inflammatory and anti-inflammatory cytokines in LPS-stimulated macrophages through distinct signaling pathways | Q24647705 | ||
Selective degradation of mitochondria by mitophagy | Q24658163 | ||
Obestatin: a new metabolic player in the pancreas and white adipose tissue | Q26824623 | ||
Novel and conventional receptors for ghrelin, desacyl-ghrelin, and pharmacologically related compounds | Q27025743 | ||
Ghrelin. | Q28081062 | ||
Uncoupling protein-2: evidence for its function as a metabolic regulator | Q28213060 | ||
Superoxide activates mitochondrial uncoupling proteins | Q28214829 | ||
Positive and negative regulation of insulin signaling through IRS-1 phosphorylation | Q28236905 | ||
Design and characterization of a fluorescent ghrelin analog for imaging the growth hormone secretagogue receptor 1a | Q28247192 | ||
Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ | Q28248705 | ||
Gut hormones and the regulation of energy homeostasis | Q28278826 | ||
Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake | Q28281470 | ||
Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone | Q28504894 | ||
Angiotensin II-induced skeletal muscle insulin resistance mediated by NF-kappaB activation via NADPH oxidase | Q28564620 | ||
Identification and characterization of a novel gastric peptide hormone: the motilin-related peptide | Q28586965 | ||
Genetic deletion of ghrelin does not decrease food intake but influences metabolic fuel preference | Q28589080 | ||
Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin | Q28590928 | ||
Absence of ghrelin protects against early-onset obesity | Q28593792 | ||
Autophagy as a regulated pathway of cellular degradation | Q29547914 | ||
Ghrelin induces adiposity in rodents | Q29619226 | ||
A role for ghrelin in the central regulation of feeding | Q29620403 | ||
Towards a multidisciplinary approach to understand and manage obesity and related diseases. | Q30240581 | ||
Acute peripheral metabolic effects of intraarterial ghrelin infusion in healthy young men. | Q30353107 | ||
The pharmacokinetics of acyl, des-acyl, and total ghrelin in healthy human subjects | Q30416543 | ||
Increased basal level of Akt-dependent insulin signaling may be responsible for the development of insulin resistance | Q30434586 | ||
Regulation of ghrelin structure and membrane binding by phosphorylation | Q30439568 | ||
Novel ghrelin assays provide evidence for independent regulation of ghrelin acylation and secretion in healthy young men. | Q30439742 | ||
Ghrelin suppresses glucose-stimulated insulin secretion and deteriorates glucose tolerance in healthy humans | Q30496263 | ||
The ghrelin cell: a novel developmentally regulated islet cell in the human pancreas. | Q30838986 | ||
Unacylated ghrelin is active on the INS-1E rat insulinoma cell line independently of the growth hormone secretagogue receptor type 1a and the corticotropin releasing factor 2 receptor. | Q30968720 | ||
Ghrelin treatment reverses the reduction in weight gain and body fat in gastrectomised mice | Q31162633 | ||
Ghrelin, a novel placental-derived hormone. | Q31836887 | ||
The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system | Q33323392 | ||
Acute administration of unacylated ghrelin has no effect on Basal or stimulated insulin secretion in healthy humans | Q33789384 | ||
Combined effects of ghrelin and higher food intake enhance skeletal muscle mitochondrial oxidative capacity and AKT phosphorylation in rats with chronic kidney disease. | Q33802142 | ||
Uncoupling protein-2 decreases the lipogenic actions of ghrelin | Q33848289 | ||
The association between hematological parameters and insulin resistance is modified by body mass index - results from the North-East Italy MoMa population study | Q33856500 | ||
Bitter taste receptors and α-gustducin regulate the secretion of ghrelin with functional effects on food intake and gastric emptying | Q34025370 | ||
A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans | Q34085069 | ||
Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. | Q34095151 | ||
The expression of ghrelin O-acyltransferase (GOAT) in human tissues | Q34190331 | ||
Genetic studies on the ghrelin, growth hormone secretagogue receptor (GHSR) and ghrelin O-acyl transferase (GOAT) genes | Q34217460 | ||
CRF type 2 receptors mediate the metabolic effects of ghrelin in C2C12 cells | Q34223469 | ||
Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans. | Q34325049 | ||
Ghrelin stimulates, whereas des-octanoyl ghrelin inhibits, glucose output by primary hepatocytes | Q34366657 | ||
Ghrelin: structure and function | Q34406050 | ||
Ghrelin protects against cobalt chloride-induced hypoxic injury in cardiac H9c2 cells by inhibiting oxidative stress and inducing autophagy | Q34418957 | ||
Genome organization, function, and imprinting in Prader-Willi and Angelman syndromes | Q34433463 | ||
Ghrelin against alendronate-induced gastric damage in rats. | Q34486158 | ||
Des-acyl ghrelin induces food intake by a mechanism independent of the growth hormone secretagogue receptor | Q34495359 | ||
Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans | Q34511955 | ||
Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue | Q34513077 | ||
Therapeutic action of ghrelin in a mouse model of colitis. | Q34525422 | ||
Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues | Q34743649 | ||
IKKbeta/NF-kappaB activation causes severe muscle wasting in mice | Q40505119 | ||
Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. | Q40674690 | ||
Unacylated ghrelin restores insulin and autophagic signaling in skeletal muscle of diabetic mice | Q40675125 | ||
Structural divergence of human ghrelin. Identification of multiple ghrelin-derived molecules produced by post-translational processing | Q40692602 | ||
Ghrelin modulates the downstream molecules of insulin signaling in hepatoma cells. | Q40766297 | ||
Structure-function studies on the new growth hormone-releasing peptide, ghrelin: minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a. | Q40840986 | ||
Desacyl ghrelin inhibits the orexigenic effect of peripherally injected ghrelin in rats | Q41674955 | ||
Unacylated ghrelin promotes skeletal muscle regeneration following hindlimb ischemia via SOD-2-mediated miR-221/222 expression | Q41833851 | ||
Ghrelin Improves Antioxidant Defense in Blood and Brain in Normobaric Hypoxia in Adult Male Rats | Q41867391 | ||
Ghrelin and des-acyl ghrelin promote differentiation and fusion of C2C12 skeletal muscle cells. | Q42026501 | ||
The mitogenic and antiapoptotic actions of ghrelin in 3T3-L1 adipocytes | Q42462638 | ||
Effects of ghrelin administration after total gastrectomy: a prospective, randomized, placebo-controlled phase II study | Q42465576 | ||
Effects of triglycerides, obesity, and starvation on ghrelin transport across the blood-brain barrier | Q42695713 | ||
Induced ablation of ghrelin cells in adult mice does not decrease food intake, body weight, or response to high-fat diet | Q42718492 | ||
Effect of desacyl ghrelin, obestatin and related peptides on triglyceride storage, metabolism and GHSR signaling in 3T3-L1 adipocytes | Q42815441 | ||
Peripheral leptin and ghrelin receptors are regulated in a tissue-specific manner in activity-based anorexia | Q42824998 | ||
Role of leptin, ghrelin, angiotensin II and orexins in 3T3 L1 preadipocyte cells proliferation and oxidative metabolism. | Q42829069 | ||
Obestatin regulates adipocyte function and protects against diet-induced insulin resistance and inflammation. | Q42834734 | ||
Localization of acyl ghrelin- and des-acyl ghrelin-immunoreactive cells in the rat stomach and their responses to intragastric pH. | Q43054676 | ||
Ghrelin promotes antioxidant enzyme activity and reduces lipid peroxidation in the rat ovary | Q43155672 | ||
Ghrelin attenuates hepatocellular injury and liver fibrogenesis in rodents and influences fibrosis progression in humans | Q43193400 | ||
Post-prandial decrease of circulating human ghrelin levels | Q43659734 | ||
Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans | Q43766536 | ||
Novel expression and functional role of ghrelin in rat testis | Q43858033 | ||
Administration of ghrelin improves inflammation, oxidative stress, and apoptosis during and after non-alcoholic fatty liver disease development | Q43995966 | ||
Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure | Q44072283 | ||
The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats | Q44165158 | ||
Evidence for the existence of distinct central appetite, energy expenditure, and ghrelin stimulation pathways as revealed by hypothalamic site-specific leptin gene therapy | Q44193797 | ||
The role of ghrelin and growth hormone secretagogues receptor on rat adipogenesis | Q44315319 | ||
Ghrelin Arg51Gln mutation is a risk factor for Type 2 diabetes and hypertension in a random sample of middle-aged subjects | Q44435391 | ||
Low Plasma Ghrelin Is Associated With Insulin Resistance, Hypertension, and the Prevalence of Type 2 Diabetes | Q44599802 | ||
Protective effects of ghrelin on ischemia/reperfusion injury in the isolated rat heart | Q44723431 | ||
Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relative to equally obese insulin-sensitive controls | Q44835010 | ||
Ghrelin degradation by serum and tissue homogenates: identification of the cleavage sites | Q44980840 | ||
The inhibition of gastric ghrelin production by food intake in rats is dependent on the type of macronutrient. | Q45000388 | ||
Gastric bypass does not normalize obesity-related changes in ghrelin profile and leads to higher acylated ghrelin fraction. | Q45009299 | ||
Ghrelin regulates mitochondrial-lipid metabolism gene expression and tissue fat distribution in liver and skeletal muscle | Q45029541 | ||
Acylated ghrelin limits fat accumulation and improves redox state and inflammation markers in the liver of high-fat-fed rats | Q45035611 | ||
Ghrelin and des-acyl ghrelin both inhibit isoproterenol-induced lipolysis in rat adipocytes via a non-type 1a growth hormone secretagogue receptor | Q45056214 | ||
Ingested medium-chain fatty acids are directly utilized for the acyl modification of ghrelin | Q45242305 | ||
Neutralizing circulating ghrelin by expressing a growth hormone secretagogue receptor-based protein protects against high-fat diet-induced obesity in mice | Q45875896 | ||
Peripheral ghrelin selectively increases Fos expression in neuropeptide Y - synthesizing neurons in mouse hypothalamic arcuate nucleus. | Q46165631 | ||
Unacylated Ghrelin: A Novel Regulator of Muscle Intermediate Metabolism With Potential Beneficial Effects in Chronic Kidney Disease | Q46278260 | ||
Unacylated ghrelin normalizes skeletal muscle oxidative stress and prevents muscle catabolism by enhancing tissue mitophagy in experimental chronic kidney disease | Q46325544 | ||
Ghrelin treatment suppresses neutrophil-dominant inflammation in airways of patients with chronic respiratory infection | Q46525026 | ||
Unacylated Ghrelin Reduces Skeletal Muscle Reactive Oxygen Species Generation and Inflammation and Prevents High-Fat Diet-Induced Hyperglycemia and Whole-Body Insulin Resistance in Rodents. | Q46603526 | ||
Endotoxin increases plasma leptin and ghrelin levels in dogs | Q46630961 | ||
Decreased circulating levels of active ghrelin are associated with increased oxidative stress in obese subjects | Q46677653 | ||
Dose dependent effects of ghrelin on pentylenetetrazole-induced oxidative stress in a rat seizure model | Q46794448 | ||
Ghrelin enhances in vivo skeletal muscle but not liver AKT signaling in rats | Q46857146 | ||
Acute effects of ghrelin administration on glucose and lipid metabolism | Q46879352 | ||
Ghrelin differentially affects hepatic and peripheral insulin sensitivity in mice | Q46950221 | ||
In vivo and in vitro antioxidant activity of ghrelin: Attenuation of gastric ischemic injury in the rat. | Q46967733 | ||
Direct stimulation of ghrelin secretion by sympathetic nerves | Q46983615 | ||
Acylated ghrelin treatment normalizes skeletal muscle mitochondrial oxidative capacity and AKT phosphorylation in rat chronic heart failure | Q47108632 | ||
Ghrelin modulates brain activity in areas that control appetitive behavior | Q34776330 | ||
TNF-alpha downregulates eNOS expression and mitochondrial biogenesis in fat and muscle of obese rodents | Q35025561 | ||
Ghrelin-induced adiposity is independent of orexigenic effects | Q35105347 | ||
Gastrointestinal regulation of food intake | Q35251043 | ||
Ghrelin improves functional survival of engrafted adipose-derived mesenchymal stem cells in ischemic heart through PI3K/Akt signaling pathway | Q35296938 | ||
AAV-mediated in vivo functional selection of tissue-protective factors against ischaemia | Q35661326 | ||
Skeletal muscle mitochondrial protein metabolism and function in ageing and type 2 diabetes | Q35748551 | ||
Expression of ghrelin receptor mRNA in the rat and the mouse brain | Q35915057 | ||
Ghrelin and energy balance: focus on current controversies | Q36074361 | ||
The gut and energy balance: visceral allies in the obesity wars | Q36080128 | ||
Characterization of adult ghrelin and ghrelin receptor knockout mice under positive and negative energy balance | Q36415884 | ||
Ghrelin: a hormone regulating food intake and energy homeostasis | Q36572840 | ||
Inhibition of ghrelin O-acyltransferase (GOAT) by octanoylated pentapeptides. | Q36825221 | ||
Insulin sensitivity: modulation by nutrients and inflammation | Q36848937 | ||
Heterogeneity of ghrelin/growth hormone secretagogue receptors. Toward the understanding of the molecular identity of novel ghrelin/GHS receptors. | Q36876106 | ||
Effect of des-acyl ghrelin on adiposity and glucose metabolism. | Q36908903 | ||
Ghrelin, obesity and diabetes | Q36950900 | ||
Appetite and metabolic effects of ghrelin and cannabinoids: involvement of AMP-activated protein kinase | Q36993599 | ||
Inflammation and insulin resistance in uremia | Q37035741 | ||
Ghrelin induces abdominal obesity via GHS-R-dependent lipid retention | Q37214991 | ||
Colocalization of ghrelin O-acyltransferase and ghrelin in gastric mucosal cells | Q37264183 | ||
Seven transmembrane G protein-coupled receptor repertoire of gastric ghrelin cells | Q37372876 | ||
GOAT links dietary lipids with the endocrine control of energy balance | Q37463007 | ||
The effects of ghrelin on inflammation and the immune system. | Q37874758 | ||
Structure, regulation and function of ghrelin. | Q37951335 | ||
Neuroendocrine and metabolic activities of ghrelin gene products | Q37953124 | ||
Ghrelin and muscle metabolism in chronic uremia. | Q37971424 | ||
GI functions of GPR39: novel biology | Q38033914 | ||
The role of obestatin in glucose and lipid metabolism. | Q38129357 | ||
Ghrelin uses Galphai2 and activates voltage-dependent K+ channels to attenuate glucose-induced Ca2+ signaling and insulin release in islet beta-cells: novel signal transduction of ghrelin | Q38300739 | ||
Unacylated ghrelin induces oxidative stress resistance in a glucose intolerance and peripheral artery disease mouse model by restoring endothelial cell miR-126 expression | Q38303220 | ||
High-fat diet with acyl-ghrelin treatment leads to weight gain with low inflammation, high oxidative capacity and normal triglycerides in rat muscle | Q38780242 | ||
Carbohydrates and insulin resistance in clinical nutrition: Recommendations from the ESPEN expert group | Q38968183 | ||
Fasting and postprandial acyl and desacyl ghrelin levels in obese and non-obese subjects. | Q39115921 | ||
Des-acyl ghrelin has specific binding sites and different metabolic effects from ghrelin in cardiomyocytes. | Q39712194 | ||
Insulin resistance in chronic uremia | Q40012782 | ||
Gender-Specific Association of Desacylated Ghrelin with Subclinical Atherosclerosis in the Metabolic Syndrome | Q47795849 | ||
Unacylated ghrelin prevents mitochondrial dysfunction in a model of ischemia/reperfusion liver injury. | Q48200734 | ||
Ghrelin and growth hormone secretagogue receptor expression in mice during aging | Q48342335 | ||
Ghrelin alleviates early brain injury after subarachnoid hemorrhage via the PI3K/Akt signaling pathway. | Q48558042 | ||
Effect of food restriction on ghrelin in normal-cycling female rats and in pregnancy | Q48629038 | ||
On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone | Q48673475 | ||
Ghrelin causes hyperphagia and obesity in rats. | Q48731123 | ||
The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors | Q49075470 | ||
Insulin resistance in obesity: an overview of fundamental alterations | Q49349613 | ||
Obesity: focus on ongoing multidisciplinary and comprehensive research | Q49913184 | ||
The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans | Q50336243 | ||
Ghrelin Attenuated Lipotoxicity via Autophagy Induction and Nuclear Factor-κB Inhibition. | Q50437715 | ||
Intravenous lipid infusion and total plasma fatty acids positively modulate plasma acylated ghrelin in vivo. | Q51288553 | ||
Leptin and ghrelin expression in adipose tissues and serum levels in gastric banding patients. | Q51498423 | ||
Increased density of ghrelin-expressing cells in the gastric fundus and body in Prader-Willi syndrome. | Q51515486 | ||
Role of ghrelin polymorphisms in obesity based on three different studies. | Q51541254 | ||
Circulating ghrelin levels are decreased in human obesity. | Q51549919 | ||
Separate measurement of plasma levels of acylated and desacyl ghrelin in healthy subjects using a new direct ELISA assay. | Q51599352 | ||
Plasma total and unacylated ghrelin predict 5-year changes in insulin resistance. | Q51669992 | ||
Hyperleptinemia prevents increased plasma ghrelin concentration during short-term moderate caloric restriction in rats. | Q52550406 | ||
Ghrelin promotes intestinal epithelial cell proliferation through PI3K/Akt pathway and EGFR trans-activation both converging to ERK 1/2 phosphorylation. | Q53076830 | ||
The effects of enteral ghrelin administration on the remodeling of the small intestinal mucosa in neonatal piglets. | Q53201466 | ||
Expression of ghrelin and its receptor in human tissues. | Q53378406 | ||
Ghrelin-producing cells exist as two types of cells, closed- and opened-type cells, in the rat gastrointestinal tract. | Q53878730 | ||
Growth hormone secretagogue binding sites in peripheral human tissues. | Q54414034 | ||
Bacterial endotoxin induces biphasic changes in plasma ghrelin in healthy humans. | Q54437059 | ||
Ghrelin protects human pulmonary artery endothelial cells against hypoxia-induced injury via PI3-kinase/Akt. | Q54451290 | ||
Ghrelin induces cell migration through GHSR1a-mediated PI3K/Akt/eNOS/NO signaling pathway in endothelial progenitor cells. | Q54467268 | ||
Elevated plasma ghrelin levels in Prader–Willi syndrome | Q56092796 | ||
Kidney produces a novel acylated peptide, ghrelin | Q61648798 | ||
Molecular screening of the ghrelin gene in Italian obese children: the Leu72Met variant is associated with an earlier onset of obesity | Q61695484 | ||
Structure-activity relationships of a synthetic pentapeptide that specifically releases growth hormone in vitro | Q71132457 | ||
Co-localization of growth hormone secretagogue receptor and NPY mRNA in the arcuate nucleus of the rat | Q73196663 | ||
Generation of polyclonal antiserum against the growth hormone secretagogue receptor (GHS-R): evidence that the GHS-R exists in the hypothalamus, pituitary and stomach of rats | Q73523502 | ||
Mutations in the preproghrelin/ghrelin gene associated with obesity in humans | Q74364847 | ||
Expression of ghrelin and of the GH secretagogue receptor by pancreatic islet cells and related endocrine tumors | Q77754388 | ||
Gut vagal afferents are not necessary for the eating-stimulatory effect of intraperitoneally injected ghrelin in the rat | Q79301454 | ||
Acylated and unacylated ghrelin promote proliferation and inhibit apoptosis of pancreatic beta-cells and human islets: involvement of 3',5'-cyclic adenosine monophosphate/protein kinase A, extracellular signal-regulated kinase 1/2, and phosphatidyl | Q79306155 | ||
Unacylated ghrelin acts as a potent insulin secretagogue in glucose-stimulated conditions | Q80499719 | ||
Relationships between desacylated and acylated ghrelin and insulin sensitivity in the metabolic syndrome | Q80672254 | ||
Moderate caloric restriction, but not physiological hyperleptinemia per se, enhances mitochondrial oxidative capacity in rat liver and skeletal muscle--tissue-specific impact on tissue triglyceride content and AKT activation | Q81196342 | ||
Higher total ghrelin levels are associated with higher insulin-mediated glucose disposal in non-diabetic maintenance hemodialysis patients | Q81249353 | ||
Fatty acids acutely enhance insulin-induced oxidative stress and cause insulin resistance by increasing mitochondrial reactive oxygen species (ROS) generation and nuclear factor-κB inhibitor (IκB)-nuclear factor-κB (NFκB) activation in rat muscle, i | Q82904528 | ||
Des-acyl ghrelin analogs prevent high-fat-diet-induced dysregulation of glucose homeostasis | Q85856335 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 997-1013 | |
P577 | publication date | 2018-10-24 | |
P1433 | published in | Eating and Weight Disorders | Q15749576 |
P1476 | title | Ghrelin forms in the modulation of energy balance and metabolism | |
P478 | volume | 24 |
Search more.